King's College London

Research portal

New cancer therapies and jaw necrosis

Research output: Contribution to journalArticlepeer-review

Vinod Patel, M. Kelleher, C. Sproat, J. Kwok, Mark McGurk

Original languageEnglish
Pages (from-to)203-207
Number of pages5
JournalBritish Dental Journal
Issue number5
Published11 Sep 2015

King's Authors


Osteonecrosis of the jaw (ONJ) has a number of causes, the most familiar being radiation or bisphosphonate induced. Various other novel anti-neoplastic and bone-targeting therapies that can also cause jaw necrosis have recently become available. This has led to the suggested acronym MRONJ for medication-related osteonecrosis of the jaw. This article summarises the available information on these drugs and their implications for the dental surgeon.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454